Job Summary
Job Description
We are looking for a Neurologist for a 6-month virtual study. The study is a Phase III, open-label, multi-center, single arm design, including 300 advancing RRMS patients. The purpose of the study is to assess early phase safety and tolerability of converting patients from approved oral and injectable RRMS DMTs. The results of this study will guide clinically relevant decisions related to the transition from frequently used RRMS DMTs. The study will provide clinically relevant data on safety and tolerability for healthcare providers who are considering converting patients from currently approved RRMS DMT.